Clinical Trial
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
2022-03-30
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30